442 related articles for article (PubMed ID: 218223)
1. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
[TBL] [Abstract][Full Text] [Related]
2. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach.
Needleman P; Whitaker MO; Wyche A; Watters K; Sprecher H; Raz A
Prostaglandins; 1980 Jan; 19(1):165-81. PubMed ID: 6247744
[TBL] [Abstract][Full Text] [Related]
4. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
[TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
6. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
Fitzpatrick FA; Gorman RR
Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships between prostacyclin and thromboxane A2.
Moncada S; Vane JR
Ciba Found Symp; 1980; 78():165-83. PubMed ID: 6258879
[TBL] [Abstract][Full Text] [Related]
8. The role of prostacyclin in vascular tissue.
Moncada S; Vane JR
Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides.
Kozak KR; Crews BC; Morrow JD; Wang LH; Ma YH; Weinander R; Jakobsson PJ; Marnett LJ
J Biol Chem; 2002 Nov; 277(47):44877-85. PubMed ID: 12244105
[TBL] [Abstract][Full Text] [Related]
11. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
12. Platelet and blood vessel arachidonate metabolism and interactions.
Needleman P; Wyche A; Raz A
J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
[TBL] [Abstract][Full Text] [Related]
13. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet.
Hill E; Fitzpatrick F; Murphy RC
Br J Pharmacol; 1992 Jun; 106(2):267-74. PubMed ID: 1327375
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandins and other metabolites of arachidonic acid. An overview for the otolaryngologist.
Poole MD; Pillsbury HC
Arch Otolaryngol; 1985 May; 111(5):317-21. PubMed ID: 2985036
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
16. 9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Heikes JE; Sprague PW; Antonaccio MJ
Prostaglandins; 1981 Aug; 22(2):295-307. PubMed ID: 6270744
[TBL] [Abstract][Full Text] [Related]
17. Platelet-endothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP.
Nalbandian RM; Henry RL
Semin Thromb Hemost; 1978; 5(2):87-111. PubMed ID: 216078
[No Abstract] [Full Text] [Related]
18. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
20. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
